Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences Revenue

Cytek Biosciences had revenue of $44.14M in the quarter ending March 31, 2026, with 6.46% growth. This brings the company's revenue in the last twelve months to $204.17M, up 3.61% year-over-year. In the year 2025, Cytek Biosciences had annual revenue of $201.49M with 0.52% growth.

• Revenue (ttm): $204.17M
• Revenue Growth: +3.61%
• P/S Ratio: 2.65
• Revenue / Employee: $301,137
• Employees: 678
• Market Cap: 541.11M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	201.49M	1.04M	0.52%
Dec 31, 2024	200.45M	7.44M	3.85%
Dec 31, 2023	193.02M	28.98M	17.67%
Dec 31, 2022	164.04M	36.09M	28.20%
Dec 31, 2021	127.95M	35.11M	37.82%
Dec 31, 2020	92.84M	34.96M	60.39%
Dec 31, 2019	57.88M	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error